SAE EIA-555-2015
验证是否符合 PPM 中指定质量水平(SQL)的批次验收程序(以前称为 TechAmerica EIA-555)

Lot Acceptance Procedure for Verifying Compliance with the Specified Quality Levels (SQL) in PPM (Formerly TechAmerica EIA-555)


SAE EIA-555-2015




购买全文,请联系:


标准号
SAE EIA-555-2015
发布
2015年
发布单位
SAE - SAE International
替代标准
SAE EIA-555-2016
当前最新
SAE EIA-555-2016
 
 
适用范围
"This Specification covers a statistical sampling plan for lot inspection by attributes. It verifies that the customer's specified quality level (SQL) is not being exceeded. The estimate of fraction nonconforming determined by EIA Interim Standard No. EIA-554 is used to select the optimum sample plan for verifying that a given lot meets the specified quality level (SQL). This specification is applicable to components: Whose overall manufacturing processes are in statistical control; Whose manufacturing processes have a distribution of nonconformances that can be approximated by a binomial probability distribution; Whose manufacturing processes have manufacturing fraction nonconforming (F) levels of approximately 30 ppm to 5000 ppm. While there is no mathematical basis for limiting the application of this specification@ when F is less than 30 ppm@ sample inspection may not be economically feasible. When F is greater than 5000 ppm other lot by lot inspection techniques may be more appropriate. The SQL range corresponding to this F range falls between 500 ppm and 75000 ppm since the SQL is likely to be on the order of 15 times the manufacturing fraction nonconforming: Those production process output per lot is ""large"" compared to the sample size. (For a lot size that is three times the sample size the alpha error is approximately 6% instead of the 10% stated and the beta error is approximately 14% instead of the 20% stated.); and Whose production process produces more than five lots per year. This sampling plan provides confirmation that steps in a process@ following prior in-process inspection@ have not introduced excessive nonconformances and that the prior in-process inspection has not passed an excessive number of nonconformances. Both the Type I (alpha) and Type II (beta) errors are fixed. An estimate of the fraction of nonconforming components that reach the inspection point is established."

SAE EIA-555-2015相似标准


推荐

检验过程确认与验证 19 条建议

建议XV 所考察检验程序应记录在符合ISO 15189SOP。 建议XVI在实施该方法时,应制定适当质量保证程序,包括内部和外部质量控制可接受限度,同时考虑到重要医学决定水平。 实施 实施新检验方法需要就确认/验证实验结果相关修改与请求者和所有其他方进行沟通。有必要制定实施程序和/或检查清单。建议XVII新或修改检验程序实施过程应在说明或检查清单列出。...

《蒲答》论坛问答一周精选(2018.08.20至26)

最主要看在偏差文件规定,内审,外审符合项怎么个流程进行处理。歪楼:好写就写写,各部门都不想整,就别难为自己了。8、【确认&验证验证报告阶段性审批怎么做合适?问:请教诸位老师,验证报告阶段性审批怎么做合适?需要每完成一个阶段都进行一次签字审批吗?各位如有类似的模板,能否让借鉴一下。答:首先要知道是怎么阶段性完成,是否每个阶段都要质量管理负责人签字?...

Drug RA | FDA新药2/3期申报CMC资料要求及专家答疑

A方法验证原则上与剂量没有关系,由于方法验证验证范围,如果15mg下符合认证参数(parameter)范围内(linear range),即可以接收。Q美国临床批是否必须是生产用于美国申报批次,申请人在境内按照目前现有批次(如中国注册批次是否可以呢,届时美国申报后,申请人保证美国临床批生产工艺等与拟用申报批次一致。...

FDA培训PPT: 工艺验证与ICHQ7

1.25%0.75%1.00%杂质4NMT5.0%NDNDND杂质5NMT0.10%NDNDND杂质6NMT10.0%0.10%0.15%9.50%批次杂质含量报告在申报资料中应提交所有批次原料药分析结果使用所拟商业化工艺生产所有批次任何高于鉴别阈水平杂质均应鉴别在建议存贮条件下稳定性研究中观察到所有降解产物如高于鉴别阈水平均应鉴别质量标准杂质列表原料药质量标准应包括杂质清单杂质应基于所拟商业化工艺生产批次中发现杂质新原料药质量标准中所包括指定可接受标准单杂被称为...





Copyright ©2007-2022 ANTPEDIA, All Rights Reserved
京ICP备07018254号 京公网安备1101085018 电信与信息服务业务经营许可证:京ICP证110310号